STEVEN M. PAUL

Insider Reports History

Location
Boston, MA
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by STEVEN M. PAUL:

Company Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. Director Common Stock 41,666 $416,243 $9.99 12 Sep 2025 By Paul Capital Strategy III Fund LLC
ALNYLAM PHARMACEUTICALS, INC. Director Common Stock 1,000 $185,320 $185.32 01 Apr 2022 Direct
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 18 Mar 2024 Direct
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 18 Mar 2024 Jann E. Paul GRAT III
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 18 Mar 2024 Jann E Paul Revocable Trust
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 18 Mar 2024 Steve M. Paul Family 2021 Delaware Trust
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 18 Mar 2024 Steven M. Paul Family 2024 Trust
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 18 Mar 2024 The Steven M Paul Revocable Trust
Karuna Therapeutics, Inc. Director Option (right to buy) 0 $0 $142.74 18 Mar 2024 Direct
Rapport Therapeutics, Inc. Director Stock Option (Right to Buy) 21,850 17 Jun 2025 Direct
Voyager Therapeutics, Inc. Director Stock Option (Right to Buy) 15,000 03 Jun 2021 Direct
Sage Therapeutics, Inc. Director Stock Options (Right to buy) 3,971 03 Jan 2024 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 0 01 Apr 2022 Direct

Insider Reports Filed by STEVEN M. PAUL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RAPP Rapport Therapeutics, Inc. 12 Sep 2025 2 +$1,027,111 4 Director 15 Sep 2025, 16:05
RAPP Rapport Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 16:15
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 0 $0 3 Director 06 Jun 2024, 18:51
/report/000114036124013933-paul-steven-m-2024-03-18 Karuna Therapeutics, Inc. 18 Mar 2024 18 -$829,620,123 4 Director 18 Mar 2024, 16:30
/report/000095017024024999-paul-steven-m-2024-02-29 Karuna Therapeutics, Inc. 29 Feb 2024 7 +$14,932,598 4 Director 04 Mar 2024, 17:34
/report/000095017024020397-paul-steven-m-2024-02-23 Karuna Therapeutics, Inc. 23 Feb 2024 4 +$599,675 4 Director 26 Feb 2024, 18:15
/report/000095017024013963-paul-steven-m-2024-02-09 Karuna Therapeutics, Inc. 09 Feb 2024 1 -$254,981 4 Director 12 Feb 2024, 17:13
SAGE Sage Therapeutics, Inc. 03 Jan 2024 1 $0 4 Director 04 Jan 2024, 16:07
SAGE Sage Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:06
/report/000089924323004747-paul-steven-m-2023-02-09 Karuna Therapeutics, Inc. 09 Feb 2023 6 $0 4 CSO and President of R&D, Director 13 Feb 2023, 15:15
SAGE Sage Therapeutics, Inc. 04 Jan 2023 1 $0 4 Director 05 Jan 2023, 15:30
SAGE Sage Therapeutics, Inc. 28 Nov 2022 1 +$191 4 Director 30 Nov 2022, 15:15
SAGE Sage Therapeutics, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:35
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Apr 2022 12 -$2,390,421 4 Director 05 Apr 2022, 16:05
/report/000159396822000495-paul-steven-m-2022-02-16 Karuna Therapeutics, Inc. 16 Feb 2022 1 $0 4 President & CEO, Director 17 Feb 2022, 16:20
SAGE Sage Therapeutics, Inc. 04 Jan 2022 1 $0 4 Director 05 Jan 2022, 15:08
SAGE Sage Therapeutics, Inc. 09 Nov 2021 1 +$43.36 4 Director 12 Nov 2021, 15:53
/report/000159396821001992-paul-steven-m-2021-08-17 Karuna Therapeutics, Inc. 17 Aug 2021 2 +$250,264 4 PRESIDENT & CEO, Director 18 Aug 2021, 19:43
ALNY ALNYLAM PHARMACEUTICALS, INC. 15 Jul 2021 1 $0 4 Director 19 Jul 2021, 16:20
SAGE Sage Therapeutics, Inc. 10 Jun 2021 1 $0 4 Director 11 Jun 2021, 16:08
VYGR Voyager Therapeutics, Inc. 03 Jun 2021 1 $0 4 Director 04 Jun 2021, 16:34